Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Other Non-Current Liabilities (2021 - 2022)

Pulmonx (LUNG) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $179000.0 as the latest value for Q2 2022.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $179000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $179000.0, a N/A change, with the full-year FY2021 number at $179000.0, changed N/A from a year prior.
  • Other Non-Current Liabilities was $179000.0 for Q2 2022 at Pulmonx, roughly flat from $179000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.2 million in Q4 2019 to a low of $179000.0 in Q4 2021.
  • A 3-year average of $434250.0 and a median of $179000.0 in 2021 define the central range for Other Non-Current Liabilities.